Articles by admin

Oct.28 — Microsoft Corp. shares rose to an intraday record after the company scored a major victory in securing a milestone, $10 billion Pentagon contract for cloud computing services. Amazon.com Inc. is considering a challenge to the award of the contract to Microsoft’s much smaller Azure business, citing President Donald Trump’s interference in the bidding process, according to a person familiar with the matter. Bloomberg’s Naomi Nix has more on “Balance of Power.” …read more […]

Yahoo Finance’s Julie Hyman, Adam Shapiro, Brian Sozzi, Kevin Mahn – Hennion & Walsh Asset Management President & Chief Investment Officer and David Williams Founder and CEO of Williams Capital Management discuss the techlash confronting Silicon Valley. …read more […]

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is… …read more […]

Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons. Nevertheless, the data show elite investors’ consensus picks have done well on average over the long-term. The top 20 stocks among hedge funds beat the S&P […] …read more […]

We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 45% and 39% respectively. Hedge funds’ top 3 stock picks returned 34.4% this year and beat the S&P […] …read more […]

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will… …read more […]

AstraZeneca Plc said on Monday a combination of its cancer drug, Imfinzi, along with chemotherapy helped curb progression of lung cancer in a late-stage study, sending its shares up 2%. The combination, when added to the drugmaker’s tremelimumab therapy, also met the secondary goal of improving progression-free survival, the British drugmaker said. The combinations were being tested in previously untreated patients with stage four, non-small cell lung cancer. …read more […]

At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […] …read more […]

Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients’ money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth also depends on it. Regardless of the various methods used by elite investors like David Tepper and David […] …read more […]

Is Endo International plc (NASDAQ:ENDP) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage […] …read more […]

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We’ll apply a… …read more […]